In the first session, IHI Executive Director Dr Pierre Meulien presented IHI and explained why we are launching a new European partnership for health. He also described what's new compared to the Innovative Medicines Initiative (IMI), and what will stay the same. IHI staff then presented opportunities for stakeholders to get involved in IHI, for example by applying to become a member of the IHI Science and Innovation Panel (SIP), or by becoming an expert evaluator. They also offered a preview of the draft topics under consideration for inclusion in the first IHI call for proposals.

The second session featured a high-level discussion during which representatives of the IHI partners, namely the European Commission, the European Parliament, COCIR, EFPIA , Vaccines Europe, EuropaBio and MedTech Europe, presented their vision for IHI.

Both sessions included time for questions from participants.

Click here for the recording and presentation .

Pierre Meulien   Executive Director, IHI	Hugh Laverty Head of Scientific Operations, IHI
Jean- Eric Paquet Director-General, DG Research and Innovation, European Commission	Bernt Bieber COCIR President & SVP Direct Sales Siemens Healthineers	Serge Bernasconi Chief Executive Officer, MedTech Europe	Claire Skentelbery Director General, EuropaBio
Sibilia Quilici Executive Director, Vaccines Europe	Nathalie Moll Director General, European Federation of Pharmaceutical Industries and Associations	Maria da Graça Carvalho Member of European Parliament

       Jennifer Baker

 Journalist and Moderator